Esperovax is a company headquartered in the United States.
Esperovax is a biotechnology company developing proprietary oral mRNA vaccine platforms to create thermostable, cost-effective, and easily distributable oral biologics for preventing and treating infectious diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.